Skip to main content

Advertisement

Log in

A Recurrent Mutation c.617G>A in the ACVR1 Gene Causes Fibrodysplasia Ossificans Progressiva in Two Chinese Patients

  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

Fibrodysplasia ossificans progressiva (FOP; OMIM 135100) is a rare heritable disorder of connective tissue characterized by congenital malformations of the great toes and recurrent episodes of painful soft tissue swelling that lead to heterotopic ossifications. Recent studies have shown that the ACVR1 (activin A receptor, type I; OMIM 102576) gene, which encodes the BMP type I receptor protein, is responsible for this disease. We observed two Chinese patients who suffered from progressive pain and ankylosis of major joints with congenital bilateral hallus valgus malformation, neck stiffness, and several posttraumatic ossified lesions on the head and dorsum. Both patients were diagnosed as having FOP. This study aimed to investigate the ACVR1 gene mutation in Chinese FOP patients. Direct sequence analysis of genomic DNA and restriction enzyme digestion demonstrated the presence of a single heterozygous c.617G>A (p.R206H) mutation in the ACVR1 gene in both patients. This mutation is first reported in Chinese patients with FOP and it was de novo in both affected families.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Kaplan FS, Shore EM, Connor JM (2002) Fibrodysplasia ossificans progressiva (FOP). In: Royce PM, Steinmann B (eds) Connective tissue and its heritable disorders: molecular, genetic, and medical aspects, 2nd edn. Wiley-Liss, New York, pp 827–840

    Google Scholar 

  2. Connor JM, Evans DAP (1982) Genetic aspects of fibrodysplasia ossificans progressiva. J Med Genet 19:35–39

    Google Scholar 

  3. Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Brown MA, Kaplan FS (2006) A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 38:525–527

    Article  PubMed  CAS  Google Scholar 

  4. Lin GT, Chang HW, Liu CS, Huang PJ, Wang HC, Cheng YM (2006) De novo 617G>A nucleotide mutation in the ACVR1 gene in a Taiwanese patient with fibrodysplasia ossificans progressiva. J Hum Genet 51:1083–1086

    Article  PubMed  Google Scholar 

  5. Nakajima M, Haga N, Takikawa K, Manabe N, Nishimura G, Ikegawa S (2007) The ACVR1 617G>A mutation is also recurrent in three Japanese patients with fibrodysplasia ossificans progressiva. J Hum Genet 52:473–475

    Article  PubMed  Google Scholar 

  6. Hao Z, Dadi J, Zongsen J, Hanqing W (2002) Myositis ossificans progressiva (MOP): literature review of 51 MOP cases in China. Chin J Clin Rehabil 22:3384–3385

    Google Scholar 

  7. Schaffer AA, Kaplan FS, Tracy MR, O’Brien ML, Dormans JP, Shore EM, Harland RM, Kusumi K (2005) Developmental anomalies of the cervical spine in patients with fibrodysplasia ossificans progressiva are distinctly different from those in patients with Klippel-Feil syndrome: clues from the BMP signaling pathway. Spine 30:1379–1385

    Article  PubMed  Google Scholar 

  8. Furuya H, Ikezoe K, Wang L, Ohyagi O, Motomura K, Fujii N, Kira J, Fukumaki Y (2008) A unique case of fibrodysplasia ossificans progressiva with an ACVR1 mutation, G356D, other than the common mutation (R206H). Am J Med Genet A 146:459–463

    Google Scholar 

  9. Kaplan FS, Xu M, Seemann P, Connor JM, Glaser DL, Carroll L, Delai P, Fastnacht-Urban E, Forman SJ, Gillessen-Kaesbach G, Hoover-Fong J, Köster B, Pauli RM, Reardon W, Zaidi SA, Zasloff M, Morhart R, Mundlos S, Groppe J, Shore EM (2009) Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Hum Mutat 30(3):379–390

    Article  PubMed  CAS  Google Scholar 

  10. Groppe JC, Shore EM, Kaplan FS (2007) Functional modeling of the ACVR1 (R206H) mutation in FOP. Clin Orthop Relat Res 462:87–92

    Article  PubMed  Google Scholar 

  11. Zhang D, Rosier RN (2003) ALK2 functions as a BMP type I receptor and induces Indian hedgehog in chondrocytes during skeletal development. J Bone Miner Res 18:1593–1604

    Article  PubMed  CAS  Google Scholar 

  12. Shafritz AB, Shore EM, Gannon FH, Zasloff MA, Taub R, Muenke M, Kaplan FS (1996) Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva. N Engl J Med 335:555–561

    Article  PubMed  CAS  Google Scholar 

  13. Olmsted EA, Kaplan FS, Shore EM (2003) Bone morphogenetic protein-4 regulation in fibrodysplasia ossificans progressiva. Clin Orthop 408:331–343

    Article  PubMed  Google Scholar 

  14. de la Peña LS, Billings PC, Fiori JL, Ahn J, Kaplan FS, Shore EM (2005) Fibrodysplasia ossificans progressiva (FOP), a disorder of ectopic osteogenesis, misregulates cell surface expression and trafficking of BMPRIA. J Bone Miner Res 20:1168–1176

    Article  PubMed  Google Scholar 

  15. Billings PC, Fiori JL, Bentwood JL, O’Connell MP, Jiao X, Nussbaum B, Caron RJ, Shore EM, Kaplan FS (2008) Dysregulated BMP signaling and enhanced osteogenic differentiation of connective tissue progenitor cells from patients with fibrodysplasia ossificans progressiva (FOP). J Bone Miner Res 3:305–313

    Article  Google Scholar 

  16. Kan L, Hu M, Gomes WA, Kessler JA (2004) Transgenic mice overexpressing BMP4 develop a fibrodysplasia ossificans progressiva (FOP)-like phenotype. Am J Pathol 165:1107–1115

    PubMed  CAS  Google Scholar 

  17. Kaplan FS, Shore EM, Gupta R, Billings PC, Glaser DL, Pignolo RJ, Graf D, Kamoun M (2005) Immunological features of fibrodysplasia ossificans progressiva and the dysregulated BMP4 pathway. Clin Rev Bone Miner Metab 3:189–193

    Article  Google Scholar 

  18. Kaplan FS, Shen Q, Lounev V, Seemann P, Groppe J, Katagiri T, Pignolo RJ, Shore EM (2008) Skeletal metamorphosis in fibrodysplasia ossificans progressiva (FOP). J Bone Miner Metab 26:521–530

    Article  PubMed  Google Scholar 

  19. Rogers JG, Geho WB (1979) Fibrodysplasia ossificans progressiva—a survey of forty-two cases. J Bone Joint Surg Am 61:909–914

    PubMed  CAS  Google Scholar 

  20. Dua T, Kabra M, Kalra Familial V (2001) Fibrodysplasia ossificans progressiva: trial with etidronate disodium. Indian Pediatr 38:1305–1309

    PubMed  CAS  Google Scholar 

  21. Kaplan FS, Xu M, Glaser DL, Collins F, Connor M, Kitterman J, Sillence D, Zackai E, Ravitsky V, Zasloff M, Ganguly A, Shore EM (2008) Early diagnosis of fibrodysplasia ossificans progressiva. Pediatrics 121:1295–1300

    Article  Google Scholar 

Download references

Acknowledgments

The authors thank Dr. Huiyuan Luo (Department of Medical Genetics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College), who provided helpful discussion. The research funding was provided by the National Natural Science Foundation of China (NSFC) under Grant No. 30370781 and the Doctoral Fund of the Ministry of Education of China under Grant No. 20040023055.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Weibo Xia.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sun, Y., Xia, W., Jiang, Y. et al. A Recurrent Mutation c.617G>A in the ACVR1 Gene Causes Fibrodysplasia Ossificans Progressiva in Two Chinese Patients. Calcif Tissue Int 84, 361–365 (2009). https://doi.org/10.1007/s00223-009-9235-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-009-9235-9

Keywords

Navigation